Foghorn Therapeutics Inc.FHTXNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank43
3Y CAGR-12.5%
5Y CAGR+52.0%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-12.5%/yr
vs +51.3%/yr prior
5Y CAGR
+52.0%/yr
Recent deceleration
Acceleration
-63.8pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
8.1x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $91.31M | -27.1% |
| 2024 | $125.28M | -11.8% |
| 2023 | $142.06M | +4.2% |
| 2022 | $136.37M | +33.6% |
| 2021 | $102.05M | +807.5% |
| 2020 | $11.25M | -77.2% |
| 2019 | $49.29M | +89.2% |
| 2018 | $26.05M | - |